Exsure Private Limited

Exsure Private Limited - chemicals in Bhubaneswar, Orissa, India. FY 2026 financials and compliance.
CIN U24239OR2021PTC038222 Incorporated 18 November 2021 ROC Cuttack HQ Bhubaneswar, Orissa, India
Active Private Limited Company chemicals
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹64,900
Issued & subscribed
Open charges
None
Secured borrowings
Company age
5 yrs
Est. 2021
Last financials
Mar 2025
Balance sheet date

About Exsure Private Limited

Data last updated: 25 February 2026

Exsure Private Limited is a private limited company based in Bhubaneswar, Orissa, India, recognised as a startup by DPIIT. It specialises in manufacturing, a part of the broader chemicals sector. Incorporated on 18 November 2021, the company has been in operation for over 5 years.

Registered with ROC Cuttack under CIN U24239OR2021PTC038222.

Capital: an authorised share capital of ₹15 Lakh and a paid-up capital of ₹64,900. It is led by directors Abhishek Dutta and Swastika Paul.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Room No.301 Kiit Tbi Campus – 11 Kiit Univeristy Patia, Bhubaneswar, Orissa, India – 751024.

The company is associated with 1 brand - Exsure.

For more details, the company can be reached via its website exsure.in.

Company Details of Exsure Private Limited
CIN U24239OR2021PTC038222
Registration Number 038222
Incorporation Date 18 November 2021
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Abhishek Dutta Director Swastika Paul Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Room No.301 Kiit Tbi Campus – 11 Kiit Univeristy Patia, Bhubaneswar, Orissa, India – 751024
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Company report
Exsure Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Exsure Private Limited report

Financials, compliance, directors, charges, ownership and filings for Exsure Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Exsure Private Limited

Exsure Private Limited operates one associated brand: Exsure. These brands represent Exsure Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Exsure
Developer of nano drug delivery platform for cancer treatment exsure.in

Competitors & Alternatives of Exsure Private Limited

Brands and companies operating in the same space as Exsure Private Limited include Moderna, Jazz Pharmaceuticals, Advanced Accelerator Applications and 6 more.

Competitor Description Location Founded
Moderna Moderna mRNA-based therapeutics for diseases including cancer and infections are developed. Cambridge, United States, United States 2010
Jazz Pharmaceuticals Jazz Pharmaceuticals Novel biopharmaceutical medicines are developed for unmet medical needs. Dublin, Ireland, Ireland 2003
Advanced Accelerator Applications Advanced Accelerator Applications Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. Saint Genis Pouilly, France, France 2002
C4 Therapeutics C4 Therapeutics Small-molecule drugs for cancer treatment are developed via Degronimid platform. Cambridge, United States, United States 2016
BeiGene BeiGene Targeted and immune-oncology drugs for cancer treatment are developed. Cambridge, United States, United States 2010
Syndax Syndax Targeted therapies for cancer treatment are developed. Waltham, United States, United States 2005
Revolution Medicines Revolution Medicines Cancer therapies are developed using selective pathway inhibitors. Redwood City, United States, United States 2014
Blueprint Medicines Blueprint Medicines Selective kinase inhibitors are developed for genomically defined cancers. Cambridge, United States, United States 2008
Incyte Incyte Small molecules are developed for cancer and skin disease treatments. Wilmington, United States, United States 1991

Board of Directors of Exsure Private Limited

Exsure Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Abhishek Dutta Director 18 Nov 2021 4 Years 7 Months Current
Swastika Paul Director 18 Nov 2021 4 Years 7 Months Current
View all directors

Financials of Exsure Private Limited FY 2025 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings Exsure Private Limited

Exsure Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Exsure Private Limited

View historical data on people associated with Exsure Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Exsure Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Exsure Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Exsure Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Exsure Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Exsure Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Exsure Private Limited

MSME Payment Delays by Exsure Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Exsure Private Limited

Subsidiaries & Group Companies of Exsure Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Exsure Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Exsure Private Limited

MCA Filings & Documents of Exsure Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Exsure Private Limited

Activity
30 Sep 2025
Exsure Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Exsure Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Cuttack.
Directors
18 Nov 2021
Abhishek Dutta was appointed as a Director on 18 Nov 2021 & has been associated with this company since 4 years 7 months.
Directors
18 Nov 2021
Swastika Paul was appointed as a Director on 18 Nov 2021 & has been associated with this company since 4 years 7 months.
Activity
18 Nov 2021
Exsure Private Limited was registered on 18 Nov 2021 with Roc Cuttack & aged 4 years 7 months as per MCA records.

Frequently Asked Questions about Exsure Private Limited

Exsure Private Limited is an active private limited company in the chemicals sector based in Bhubaneswar, Orissa, India. It was incorporated on 18 November 2021 (5+ years old) and is registered under CIN U24239OR2021PTC038222.

The current directors of Exsure Private Limited are:

The primary industry of Exsure Private Limited is chemicals. The company specifically operates in manufacturing. The company is currently active in this sector.

Yes, Exsure Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Exsure Private Limited can be reached at the registered office: Room No.301 Kiit Tbi Campus – 11 Kiit Univeristy Patia, Bhubaneswar, Orissa, India – 751024, or through the website exsure.in.

The authorised capital is ₹15 Lakh, and the paid-up capital is ₹64,900.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available